Published on 08/12/2025

Ground Truth Management: Versioning and Traceability

This article serves as a comprehensive step-by-step tutorial guide on the validation of AI and machine learning (ML) models in Good Practice (GxP) analytics. As regulatory compliance becomes increasingly stringent, understanding the concepts of ground truth management, intended use, data readiness and bias, model verification and validation, as well as drift monitoring and re-validation is paramount for professionals in the pharmaceutical sector. This guide will leverage frameworks established by the US FDA, EMA, MHRA, and PIC/S, amongst other regulatory bodies.

1. Understanding AI/ML Model Validation in a GxP Context

AI/ML model validation is critical in ensuring that models operate as intended in regulated environments. It encompasses a series of planned activities aimed at ensuring that AI and ML models are capable of producing results that meet their intended use, thus addressing the concept of intended use risk.

• The term intended use refers to the objectives for which an AI model is deployed, including its application, context, and the type of decisions it influences.
• Regulatory frameworks, such as 21 CFR Part 11, demand stringent adherence to quality and validation standards, ensuring that data is trusted and compliant.

Step 1: Defining Intended Use

The first step in the validation process is clearly defining the model’s intended use. This involves:

• Identifying the specific problem the model is designed to solve.
• Detailing the target population for model deployment.
• Establishing the metrics for assessing model performance.

Effective documentation of the intended use serves as the foundation for all subsequent validation efforts. It provides a baseline against which the model’s performance can be measured. The regulatory expectations for documentation can often be explored in the guidelines issued by the EMA and WHO.

Step 2: Data Readiness and Curation

Once the intended use is established, the next step is to ensure data readiness. This involves curation of data that is:

• Relevant to the intended use.
• Representative of the conditions under which the model will operate.
• Free from biases that could skew model results.

Bias and fairness testing should be undertaken to ensure that the model does not produce skewed or unfair outcomes. This step not only mitigates compliance risks but also enhances the credibility of the model’s predictions.

Step 3: Model Implementation

The heart of AI/ML model validation lies in adhering to a rigorous verification and validation (V&V) framework. This component ensures that the model is performing as intended under various conditions.

• Model Verification serves to ensure that the model has been constructed correctly according to specifications, and is free of errors.
• Model Validation aims to confirm the model’s performance against the defined intended use and acceptance criteria.

Documentation of these processes is crucial, as it will be subject to audit trails and regulatory scrutiny. The use of GAMP 5 framework, which encourages a risk-based approach to compliance, can greatly aid organizations in establishing sound validation practices.

2. Bias and Fairness Testing

Bias and fairness testing must be an integral part of AI/ML model validation in GxP analytics. Failure to address biases can lead to misinterpretations and unreliable outputs, which are critical in the pharmaceutical domain.

Step 1: Identifying Biases

The first step in conducting bias testing is identifying potential biases that exist within the data. This can take various forms, including:

• Sampling bias: where training data does not represent the target population.
• Measurement bias: inaccuracies that arise in how data is collected.
• Algorithmic bias: where the model inherently amplifies certain inaccuracies present in the training data.

Step 2: Implementing Testing Protocols

Once biases have been identified, it is essential to implement testing protocols designed to evaluate the fairness of the model. Popular assessment techniques include:

• Confusion matrices for classification tasks to analyze prediction errors.
• Statistical Fairness Metrics to measure disparities in model outcomes.

The results of these tests should be documented meticulously to demonstrate compliance with ethical standards and regulatory requirements. Incorporate reference models and techniques as benchmarks for fair practices.

3. Model Explainability (XAI)

Explainability of AI/ML models is increasingly becoming a key regulatory requirement. The goal of Explainable AI (XAI) is to ensure that model outputs are interpretable by users and regulators alike.

Step 1: Implementing Explainability Techniques

There are various techniques for achieving explainability in AI models, including:

• SHAP (SHapley Additive exPlanations) values provide insight into how different features affect model predictions.
• LIME (Local Interpretable Model-Agnostic Explanations) focuses on the interpretability of specific model outcomes.

Implementing these techniques helps enhance user confidence and regulatory compliance by ensuring that stakeholders understand how decisions are made.

Step 2: Documentation of Explainability

Thorough documentation of explainability practices is vital to maintaining transparency. This documentation should encompass:

• The methodologies utilized to ensure explainability.
• Examples illustrating the interpretability of the model’s predictions.
• Any limitations of the model and the assumptions made during development.

Documenting explainability fosters trust in AI applications, thereby aligning with the governance and security aspects of AI deployment.

4. Drift Monitoring and Re-Validation

The dynamic nature of real-world environments necessitates ongoing monitoring of AI/ML models to mitigate the risk of performance degradation, commonly referred to as model drift.

Step 1: Establishing Drift Monitoring Protocols

Monitoring protocols should be established to detect when a model begins to deviate from its expected performance. Techniques include:

• Performance degradation tracking: Ongoing evaluation of model outputs against pre-defined metrics.
• Data drift analysis: Continuous monitoring of input data distributions to identify shifts that may affect predictions.

Step 2: Conducting Re-Validation

Re-validation should occur whenever significant drift is detected. It includes:

• Reviewing the model against the initial validation requirements.
• Running new tests to ensure the model continues to meet the standards for intended use.

Re-validation not only helps in conforming with regulatory standards but also in maintaining model relevance in a rapidly evolving landscape.

5. Documentation and Audit Trails

Proper documentation and maintenance of audit trails are non-negotiable elements of AI/ML model validation. They ensure compliance, reproducibility, and traceability of the validation processes.

Step 1: Creating Comprehensive Documentation

Every stage of the model’s lifecycle should be meticulously documented, including:

• Model development processes and methodologies.
• Validation protocols, results, and adjustments made based on bias testing and explainability assessments.
• Monitoring activities and outcomes.

Step 2: Implementing Audit Trails

Establishing audit trails is essential for tracking any changes made during the model’s lifecycle. Maintaining robust audit trails involves:

• Documenting all alterations to the model’s code.
• Recording decision-making rationales related to model adjustments or retraining.

Audit trails not only facilitate compliance with regulatory requirements but also serve as crucial evidence during inspections from regulators such as the FDA or MHRA.

6. AI Governance and Security

AI governance involves establishing policies and frameworks that guide the ethical and appropriate use of AI technologies in operational practices.

Step 1: Establishing Governance Frameworks

Develop governance frameworks that articulate the organizational strategies for responsible AI deployment. Key components include:

• Responsibilities and roles associated with AI development and deployment.
• Guidelines for ethical considerations and compliance with applicable laws.

Step 2: Implementing Security Measures

Security is paramount in any regulatory environment involving AI systems. Considerations include:

• Implementing access control measures to ensure that only authorized personnel can modify or influence model parameters.
• Incorporating regular security assessments to identify and mitigate vulnerabilities.

By aligning governance and security strategies with regulatory expectations under frameworks such as GAMP 5, organizations can significantly enhance their AI operations.

Conclusion

In conclusion, ground truth management through versioning and traceability in AI/ML model validation in GxP analytics encompasses a series of meticulous steps aimed at ensuring compliance, ethical usage, and continued performance of AI systems. By rigorously defining intended use, preparing data, conducting bias and fairness testing, ensuring model explainability, and establishing effective governance and security measures, pharmaceutical professionals can maintain high standards of quality and trust in AI applications. Ensuring that these processes align with regulatory requirements as outlined by bodies such as the FDA, EMA, and MHRA not only aids in compliance but also in achieving operational excellence and stakeholder confidence.